Adrenoceptor involvement in the cardiovascular responses to B-HT 920 in sinoaortic denervated rats

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 29-34

  Ricci, Daniel ^a   Taira, Carlos Alberto ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Adrenoceptor; B HT 920; Blood pressure; Imidazoline receptor; Sinoaortic denervation

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROETHYLCLONIDINE; CLONIDINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; PRAZOSIN; TALIPEXOLE; YOHIMBINE;

ANIMAL MODEL; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DENERVATION; HYPERTENSION; HYPOTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SINUS NODE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; AZEPINES; BLOOD PRESSURE; DENERVATION; HEART RATE; MALE; PRESSORECEPTORS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC;

EID: 0032890383     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00018-4     Document Type: Article

References (44)

1. Aksamit T.R., Floras J.S., Victor R.G. Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans. Hypertension. 9:1987;309-314.
2. Bousquet P., Schwartz J. α-Adrenergic drugs. pharmacological tools for the study of the central vasomotor control Biochem. Pharmac. 32:1983;1459-1465.
3. Bousquet P., Feldman J., Schwartz S. Central cardiovascular effects of α adrenergic drugs. differences between catecholamines and imidazolines J. Pharmac. Exp. Ther. 230:1984;232-236.
4. Bousquet P., Feldman J., Tibirica E., Bricca G., Greney H., Dontenwill M., Stutzmann J., Belcourt A. Imidazoline receptors. a new concept in central regulation of the arterial blood pressure Am. J. Hypertens. 5:1992;S47-S50.
5. Brody M.J., O'Neill T.P.O., Porter J.P. Role of central catecholaminergic systems in pathogenesis and treatment of hypertension. J. Cardiovasc. Pharmac. 5:1984;S727-S741.
6. Bruning J.L., Kintz B.L. Computational Handbook of Statistics. 2:1977;Scott, Foresman, Glenview, IL. p. 113.
7. Buccafusco J.J. Neuropharmacologic and behavioral actions of clonidine. interactions with central neurotransmitters Int. Rev. Neurobiol. 33:1992;55-107.
8. 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmac. Exp. Ther. 273:1995;1162-1171.
9. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R. Jr., Trendelenburg U. IV. International Union of Pharmacology Nomenclature of Adrenoceptors Pharmac. Rev. 46:1994;121-136.
10. De Groot J. The Rat Forebrain in Stereotaxic Coordinates. 1959;NV Noord-Hollandsche Uitgevers Maatschappij, Amsterdam.
11. 2-adrenoceptors Br. J. Pharmac. 78:1983;489-505.
12. Doxey J.C., Lane A.C., Roach A.G., Virdee N.K. Comparison of the α-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rawolscine and corynanthine. Naunyn Schmiedeberg's Arch. Pharmac. 325:1984;136-144.
13. Ebihara H., Kawasaki H., Nakamura S., Takasaki K., Wada A. Pressor response to microinjection of clonidine into the hypothalamic paraventricular nucleus in conscious rats. Brain Res. 624:1993;44-52.
14. Ernsberger P., Giuliano R., Willette R., Reis D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmac. Exp. Ther. 253:1990;408-418.
15. 3H] idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur. J. Pharmac. 146:1988;345-348.
16. 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmac. 97:1989;691-700.
17. Kawasaki H., Takasaki K. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats. J. Pharmac. Exp. Ther. 236:1986;810-818.
18. King K.A., Pang C.C.Y. Differential cardiovascular effects of central clonidine and B-HT 920 in conscious rats. Can. J. Physiol. Pharmac. 66:1988;1455-1460.
19. Kobinger W. Central α-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmac. 81:1978;40-100.
20. Kobinger W., Pichler L. Pharmacological characterization of BH-T 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepin dihydrochloride) as a hypotensive agent of the clonidine-type. Naunyn-Schmiedeberg's Arch. Pharmac. 300:1977;39-46.
21. Korner P.I., Head G.A., Badoer E. Effects of sinoaortic denervation on the acute circulatory responses to centrally administered 6-hydroxy-dopamine and clonidine in conscious rabbits. J. Cardiovasc. Pharmac. 6:1984;909-913.
22. Krieger E.M. Neurogenic hypertension in the rat. Circ. Res. 15:1964;511-521.
23. Kubo T., Misu Y. Pharmacological characterization of the α-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat. Naunyn-Schmiedeberg's Arch. Pharmac. 317:1981;120-125.
24. Mancia G., Bertinieri G., Cavallazzi A., Di Rienzo M., Paratti G., Pomidossi G., Ramirez A.J., Zanchetti A. Mechanisms of blood pressure variability in man. Clin. Exp. Hypertens. Theory Pract. (A7):1985;167-168.
25. ++. Pharmac. Rev. 40:1988;87-94.
26. 3H] prazosin binding Mol. Pharmac. 29:1986;321-330.
27. Norman R.A. Jr., Coleman T.G., Dent A.C. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension. 3:1981;119-125.
28. Piascik M.T., Sparks M.S., Pruitt T.A. Effect of chloroethylclonidine on arterial blood pressure and heart rate in the conscious rat. J. Pharmac. Exp. Ther. 262:1992;901-906.
29. Ramirez A.J., Bertinieri G., Belli L., Caballazzi A., Di Rienzo M., Pedotti A., Mancia G. Reflex control of blood pressure and heart rate by arterial baroreceptors and by cardiopulmonary receptors in the unanesthetized cat. J. Hypertens. 3:1985;327-335.
30. Reis D.J., Regunathan S., Meeley M.P. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion. Am. J. Hypertens. 5:1992;S51-S57.
31. Ricci D., Taira C.A. Sub-tipos de receptores adrenergicos involucrados en las respuestas cardiovasculares a la clonidina. Acta Farm. Bonaerense. 13:1994;29-33.
32. Ricci D., Taira C.A. Imidazoline and adrenoceptor involvement in cardiovascular responses to clonidine in sham and sinoaortic denervated rats. Ann. N.Y. Acad. Sci. 763:1995;570-573.
33. 1-adrenoceptor in the cardiovascular responses to BHT-920 and phenylephrine. Gen. Pharmac. 27:1996;299-304.
34. 2-adrenoceptor agonists. Eur. J. Pharmac. 212:1992;195-200.
35. Ruffolo R.R. Jr., Turowsky B.S., Patil P.N. Lack of cross-desensitization between structurally dissimilar α-adrenoceptor agonists. J. Pharm. Pharmac. 29:1997;378-380.
36. Sannajust F., Cerutti C., Koenig-Bérard E., Sassard J. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br. J. Pharmac. 105:1992;542-548.
37. 2-adrenoceptors and nonadrenergic idazoxan. binding sites in rabbit colon epithelial cells Eur. J. Pharmac. 191:1990;59-68.
38. 2-adrenergic receptors in nucleus tractus solitarius is required for the baroreceptor reflex. Brain Res. 576:1992;297-303.
39. Taira C.A., Celuch S.M., Enero M.A. Effects of acute and short-term treatment with antihypertensive drugs in sinoaortic denervated rats. Gen. Pharmac. 14:1983;657-661.
40. 1-adrenergic receptor subtypes. FASEB J. 3:1989;588-596.
41. Timmermans P.B.M.W.M., Qian J.Q., Ruffolo R.R. Jr., Pieter A., Van Zwieten P.A. A study of the selectivity and potency of rawolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors. J. Pharmac. Exp. Ther. 228:1984;739-748.
42. Trolin G. Effects of pentobarbitone and decerebration on the clonidine-induced circulatory changes. Eur. J. Pharmac. 34:1975;1-7.
43. Van Zwieten P.A. Antihypertensive drugs with a central action. Prog. Pharmac. 1:1975;1-63.
44. Wilson V.G., Brown C.M., McGrath J.C. Are there more than two types of α-adrenoceptors involved in physiological responses? Exp. Physiol. 76:1991;317-346.